Popular Articles

Natco Pharma FY09 net rises 8.5% at Rs 44 cr
Hyderabad-based drug maker Natco Pharma reported an 8.5 per cent rise in its consolidated net profit at Rs 43.98 crore for the year ended March 2009, compared with Rs 40.52 crore posted in the previous year.

Double triumph
The Nano and IPL come on top, Swift Dzire springs a surprise in the 13th annual Brand Derby

News of the day

'JNNURM has taken on a whole-slum approach'
Vandana Gombar / New Delhi November 26, 2009, 1:00 IST
Public Company

Swiss cement maker Holcim sees 'satisfactory' biz in India

Swiss cement maker Holcim today said its strong presence in emerging markets, including India, has helped the company balance the fall in earnings in other regions. - Holcim Q1 slumps 80%; sees strong sales in India - Ambuja net marginally rises by 2.4% - Holcim mulls more quality assets buy in India - Cement oversupply coming, says ACC - 85% of global executives think risk mgt necessary: Accenture - "Govt needs to spend more on social sector" Holcim has significant stakes in Indian cement makers ACC and Ambuja Cements. "Some markets like the US, Spain and Eastern Europe are still difficult. On the other hand, in Asia – eg in India – and in Latin America, Holcim sees a quite satisfactory trading acitivity. "All in all, the strong presence in emerging markets has slowed down the negative EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortisation) growth," Holcim said in a statement today. Noting that there was no reversal of the underlying economic trend visible up to May, Holicm said that the trading activity remained restrained. The Swiss entity reiterated that 2009 would turn out to be a difficult year. Meanwhile, the company plans to raise as much as 2.1 billion Swiss francs (about $1.93 billion) through a rights issue.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):